Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CMO’ operating in the Biotechnology space. If you think a CMO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Aris Papageorghiou
Co-Founder & CMO of Intelligent Ultrasound
Aris Papageorghiou is the Professor of Fetal Medicine at University of Oxford.
Follow Aris Papageorghiou:
About Intelligent Ultrasound, Royal College of Obstetricians and Gynaecologists, St Georges University Hospitals NHS Foundation Trust, Ultrasound Diagnostic Services, University of Oxford: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Alastair MacKinnon
CMO and Co-Founder of Mereo Biopharma
Alastair joined the team in 2005. He serves as Board Observer for Albireo and Chroma. Further to these he has been actively involved in the investments in OncoMed (OMED), Proteolix and Nabriva. Prior to joining, Alastair was a practising physician, with a breadth of experience across cardiovascular and oncology surgery and intensive care. He holds a Physiology BSc (Hons) and MBBS from King’s College London, is a Member of the Royal College of Surgeons (Ed) and hold s a Diploma in Corporate Finance from the London Business School.
Follow Alastair MacKinnon:
About Mereo Biopharma: Mereo is a new UK-based speciality biopharmaceutical company.
Alan Davies
CMO of Edinburgh Molecular Imaging
Over 25 years-experience as a Medical Director in the pharmaceutical and med tech industry, working globally to address major health issues including early cancer detection, most recently as CMO for GE Healthcare.
Follow Alan Davies:
About Edinburgh Molecular Imaging: Edinburgh Molecular Imaging is a developer of optical molecular imaging technology.
Alan Davies
CMO of Edinburgh Molecular Imaging
Over 25 years-experience as a Medical Director in the pharmaceutical and med tech industry, working globally to address major health issues including early cancer detection, most recently as CMO for GE Healthcare.
Follow Alan Davies:
About Edinburgh Molecular Imaging: Edinburgh Molecular Imaging is a developer of optical molecular imaging technology.
Pavel Pisa
CMO of Crescendo Biologics
Before joining Crescendo, Pavel was the Head of Translational Medicine at Roche and Genentech where he led over 50 programs through early and late clinical development. As both a physician and a scientist, he has in-depth knowledge of the real-life experimental and clinical challenges associated with delivering highly innovative medicines and has successfully translated scientific findings into transformative medicines such as Avastin and Gazyva, leading to significant improvement in the lives of cancer patients. Pavel has a distinguished academic, clinical and scientific career at world-leading medical institutions. He was Professor of Clinical Experimental Oncology at the Karolinska Institutet, Stockholm and has held positions at NIH, MD Anderson Cancer Center and Scripps Research Institute. He is the author of 115 highly-cited publications and patents within tumour immunology. Pavel holds a medical degree and a doctorate in medicine in Natural Killer Cells in the clinic from Charles University, Prague, as well as a PhD in Immunology from the Karolinska Institutet.
Follow Pavel Pisa:
About Crescendo Biologics: Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.
Tony Wilcox
Chief Marketing & Commercial Officer of Neurovalens
Follow Tony Wilcox:
About Henley Investment, ModiusHealth, Neurovalens: Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology
Neal L Millar
Co Founder & CMO of Causeway Therapeutics
Neal is an Academic Consultant Orthopaedic Surgeon specialising in shoulder surgery having completed fellowships in Sydney and New York and is an expert in human tendinopathy.
Follow Neal L Millar:
About Causeway Therapeutics, University of Glasgow, University of Glasgow: A bio pharmaceutical spin out emerging.
Mark Lowdell
CSO, Founder & CMO of INmuneBIO
CSO INmuneBio Inc.
Follow Mark Lowdell:
About Achilles Therapeutics, INmuneBIO, The Royal Free: INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.
